Table 1.
Cumulative descriptive statistical analysis
| Patient groups | |||
|---|---|---|---|
| GBM | CM | Total | |
| Total patients | 115 | 121 | 236 |
| Pre-COVID group | 58 | 67 | 125 |
| COVID group | 57 | 54 | 111 |
| Age (years) | |||
| Median | 67 | 65 | 65 |
| Minimum | 33 | 37 | 33 |
| Maximum | 83 | 85 | 85 |
| Gender | |||
| Female | 49 | 54 | 103 |
| Male | 66 | 67 | 133 |
| Surgical procedure | |||
| Biopsy | 56 | 9 | 65 |
| Resection | 59 | 112 | 171 |
| MGMT promotor status | NA | ||
| Methylated | 74 | - | |
| Not methylated | 41 | - | |
| Spread of metastasis | NA | ||
| Only CNS involvement | 59 | - | |
| CNS and extra-CNS involvement | 62 | - | |
| Primary tumor | |||
| Lung cancer | NA | 32 | - |
| Gastrointestinal tract cancer | NA | 22 | - |
| Malignant melanoma | NA | 16 | - |
| Breast cancer | NA | 9 | - |
| Other (renal, CUP) | NA | 31 | - |
| KPS | |||
| KPS ≥ 70% | 109 | 115 | 224 |
| KPS < 70% | 6 | 6 | 12 |
| RT | |||
| Yes | 90 | 94 | 184 |
| No | 25 | 25 | 52 |
| Tumor volume (cm3) | |||
| Median | 28.60 | 13.5 | 17.7 |
| SD | 24.15 | 18.07 | 22.14 |
| Maximum | 111.4 | 69.40 | 111.4 |
| Minimum | 0.53 | 0.30 | 0.30 |
| Tumor volume (cm3), pre-COVID group | |||
| Median | 25.65 | 12.10 | |
| SD | 22.78 | 18.54 | |
| Maximum | 83.70 | 69.40 | |
| Minimum | 0.53 | 0.30 | |
| Tumor volume (cm3), COVID group | |||
| Median | 31.50 | 16.80 | |
| SD | 25.35 | 17.46 | |
| Maximum | 111.4 | 62.90 | |
| Minimum | 1.10 | 0.82 | |